Plançon Morgane, Ridley Ashley, Lamore Kristopher, Tarot Andréa, Burnod Alexis, Blot François, Colombet Isabelle
Palliative Care Mobile Unit, General Hospital, Valenciennes, France.
Centre Hospitalier de Valenciennes, Avenue Désandrouin, Valenciennes, 59322, France.
BMC Palliat Care. 2024 Dec 6;23(1):279. doi: 10.1186/s12904-024-01608-y.
Early palliative care interventions in oncology, as recommended by international oncology societies, promote patient understanding and support decision-making. At the same time, shared decision-making models are being developed to enhance patient participation as part of a new model of patient-physician relationship. For patients with palliative needs, this participation is essential and helps to avoid futile and aggressive treatments at the end of life. The aim of this study is to observe decision making during meetings between oncology and palliative care professionals, focusing particularly on the components of shared decision-making models, but also on the role played by palliative care professionals.
We conducted a non-participant observation of multidisciplinary meetings and outpatient clinic activities in two Comprehensive Cancer Centres in France. Field notes were then coded using thematic content analysis. Deductive analysis was conducted using the observation grid developed from Elwyn's three-talk model.
Only a few elements of the different models of shared decision-making are apparent in the multidisciplinary meetings. Palliative care professionals emphasise the importance of involving patients and providing them with information about the advantages and disadvantages of different treatment options. However, patient involvement in decision-making remains difficult in daily practice. Decisions to discontinue oncological treatment are often driven by clinical and biological signs of terminal evolution rather than shared decision-making.
There are still cultural and organisational barriers to actual implementation of early integrated onco-palliative care. Promotion of shared decision making can be a strong lever of change which is frequently mobilised by palliative care teams.
正如国际肿瘤学会所推荐的,肿瘤学中的早期姑息治疗干预措施可促进患者理解并支持决策制定。与此同时,正在开发共享决策模型,以加强患者参与,作为新型医患关系模式的一部分。对于有姑息治疗需求的患者而言,这种参与至关重要,有助于避免在生命末期进行无效和激进的治疗。本研究的目的是观察肿瘤学和姑息治疗专业人员会议期间的决策过程,特别关注共享决策模型的组成部分,以及姑息治疗专业人员所发挥的作用。
我们对法国两个综合癌症中心的多学科会议和门诊活动进行了非参与性观察。然后使用主题内容分析法对实地记录进行编码。使用从埃尔温的三谈模型开发的观察网格进行演绎分析。
在多学科会议中,不同共享决策模型中只有少数要素较为明显。姑息治疗专业人员强调让患者参与并向他们提供不同治疗方案优缺点信息的重要性。然而,在日常实践中,让患者参与决策仍然困难。停止肿瘤治疗的决定通常由终末期进展的临床和生物学体征驱动,而非共享决策。
早期综合肿瘤姑息治疗的实际实施仍然存在文化和组织障碍。促进共享决策可以成为变革的有力杠杆,姑息治疗团队经常会动用这一杠杆。